Integrative Hyperphosphorylation of the Cardiac Ryanodine Receptor at Serine 2808 Is Not Involved in Cardiac Dysfunction After Myocardial Infarction

Rationale: Abnormal behavior of the cardiac ryanodine receptor (RyR2) has been linked to cardiac arrhythmias and heart failure (HF) after myocardial infarction (MI). It has been proposed that protein kinase A (PKA) hyperphosphorylation of the RyR2 at a single residue, Ser-2808, is a critical mediator of RyR dysfunction, depressed cardiac performance, and HF after MI. Objective: We used a mouse model (RyRS2808A) in which PKA hyperphosphorylation of the RyR2 at Ser-2808 is prevented to determine whether loss of PKA phosphorylation at this site averts post MI cardiac pump dysfunction. Methods and Results: MI was induced in wild-type (WT) and S2808A mice. Myocyte and cardiac function were compared in WT and S2808A animals before and after MI. The effects of the PKA activator Isoproterenol (Iso) on L-type Ca 2 (cid:1) current ( I CaL ), contractions, and [Ca 2 (cid:1) ] I transients were also measured. Both WT and S2808A mice had depressed pump function after MI, and there were no differences between groups. MI size was also identical in both groups. L type Ca 2 (cid:1) current, contractions, Ca 2 (cid:1) transients, and SR Ca 2 (cid:1) load were also not significantly different in WT versus S2808A myocytes either before or after MI. Iso effects on Ca 2 (cid:1) current, contraction, Ca 2 (cid:1) transients, and SR Ca 2 (cid:1) load were identical in WT and S2808A myocytes before and after MI at both low and high concentrations. Conclusions: These results strongly support the idea that PKA phosphorylation of RyR-S2808 is irrelevant to the development of cardiac dysfunction after MI, at least in the mice used in this study. ( Circ Res . 2012;110:831-840.)

[1]  Guang S. Liu,et al.  Defective Ca(2+) handling proteins regulation during heart failure. , 2011, Physiological research.

[2]  W. Koch,et al.  A Novel and Efficient Model of Coronary Artery Ligation and Myocardial Infarction in the Mouse , 2010, Circulation research.

[3]  T. Eschenhagen.  Is ryanodine receptor phosphorylation key to the fight or flight response and heart failure? , 2010, The Journal of clinical investigation.

[4]  S. Reiken,et al.  Role of chronic ryanodine receptor phosphorylation in heart failure and β-adrenergic receptor blockade in mice. , 2010, The Journal of clinical investigation.

[5]  M. Mongillo,et al.  Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice. , 2010, The Journal of clinical investigation.

[6]  S. Houser,et al.  Enhanced basal contractility but reduced excitation-contraction coupling efficiency and beta-adrenergic reserve of hearts with increased Cav1.2 activity. , 2010, American journal of physiology. Heart and circulatory physiology.

[7]  S. Huke,et al.  Kinetics of FKBP12.6 Binding to Ryanodine Receptors in Permeabilized Cardiac Myocytes and Effects on Ca Sparks , 2010, Circulation research.

[8]  Javed Butler,et al.  The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. , 2009, Journal of the American College of Cardiology.

[9]  S. Huke,et al.  Ryanodine receptor phosphorylation at Serine 2030, 2808 and 2814 in rat cardiomyocytes. , 2008, Biochemical and Biophysical Research Communications - BBRC.

[10]  David M. Harris,et al.  Reduced effects of BAY K 8644 on L-type Ca2+ current in failing human cardiac myocytes are related to abnormal adrenergic regulation. , 2008, American journal of physiology. Heart and circulatory physiology.

[11]  S. Houser,et al.  Adrenergic Regulation of Cardiac Contractility Does Not Involve Phosphorylation of the Cardiac Ryanodine Receptor at Serine 2808 , 2008, Circulation research.

[12]  Wenjun Xie,et al.  Functional Consequence of Protein Kinase A-dependent Phosphorylation of the Cardiac Ryanodine Receptor , 2007, Journal of Biological Chemistry.

[13]  P. Powers,et al.  Intact &bgr;-Adrenergic Response and Unmodified Progression Toward Heart Failure in Mice With Genetic Ablation of a Major Protein Kinase A Phosphorylation Site in the Cardiac Ryanodine Receptor , 2007, Circulation research.

[14]  W. Koch,et al.  Darbepoetin alfa, a long-acting erythropoietin analog, offers novel and delayed cardioprotection for the ischemic heart. , 2007, American journal of physiology. Heart and circulatory physiology.

[15]  David M. Harris,et al.  Adolescent Feline Heart Contains a Population of Small, Proliferative Ventricular Myocytes With Immature Physiological Properties , 2007, Circulation research.

[16]  Donald M Bers,et al.  Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase. , 2007, Circulation research.

[17]  S. Reiken,et al.  Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  G. Vetrovec,et al.  Acute myocardial infarction and heart failure: role of apoptosis. , 2006, The international journal of biochemistry & cell biology.

[19]  Donald M Bers,et al.  Regulation of cardiac sarcoplasmic reticulum Ca release by luminal [Ca] and altered gating assessed with a mathematical model. , 2005, Biophysical journal.

[20]  Douglas L Mann,et al.  Mechanisms and models in heart failure: the biomechanical model and beyond. , 2005, Circulation.

[21]  Y. Taur,et al.  The Cardiac Ryanodine Receptor (RyR2) and Its Role in Heart Disease , 2005, Cardiology in review.

[22]  M. Yano,et al.  Altered intracellular Ca2+ handling in heart failure. , 2005, The Journal of clinical investigation.

[23]  K. P. Roos,et al.  Functional Adult Myocardium in the Absence of Na+-Ca2+ Exchange: Cardiac-Specific Knockout of NCX1 , 2004, Circulation research.

[24]  Jose L Puglisi,et al.  Modeling the isolated cardiac myocyte. , 2004, Progress in biophysics and molecular biology.

[25]  D. Bers,et al.  Modulation of excitation–contraction coupling by isoproterenol in cardiomyocytes with controlled SR Ca2+ load and Ca2+ current trigger , 2004, The Journal of physiology.

[26]  Donald M Bers,et al.  Cellular Basis of Abnormal Calcium Transients of Failing Human Ventricular Myocytes , 2003, Circulation research.

[27]  Masashi Inoue,et al.  Ca2+ Sparks in Rabbit Ventricular Myocytes Evoked by Action Potentials: Involvement of Clusters of L-Type Ca2+ Channels , 2003, Circulation research.

[28]  K. Wagner,et al.  Transgenic overexpression of the sarcoplasmic reticulum Ca2+ ATPase improves reticular Ca2+ handling in normal and diabetic rat hearts , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  Steven R Houser,et al.  L-Type Ca2+ Channel Density and Regulation Are Altered in Failing Human Ventricular Myocytes and Recover After Support With Mechanical Assist Devices , 2002, Circulation research.

[30]  D. Bers,et al.  Protein Kinase A Phosphorylation of the Ryanodine Receptor Does Not Affect Calcium Sparks in Mouse Ventricular Myocytes , 2002, Circulation research.

[31]  S. Marx,et al.  Progression of heart failure: is protein kinase a hyperphosphorylation of the ryanodine receptor a contributing factor? , 2002, Circulation.

[32]  S. Priori,et al.  Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia , 2002, Journal of cellular physiology.

[33]  Héctor H. Valdivia,et al.  Abnormal Ca 2 Release , but Normal Ryanodine Receptors , in Canine and Human Heart Failure , 2002 .

[34]  S. Houser,et al.  Patients With End-Stage Congestive Heart Failure Treated With &bgr;-Adrenergic Receptor Antagonists Have Improved Ventricular Myocyte Calcium Regulatory Protein Abundance , 2001, Circulation.

[35]  W. Lederer,et al.  Heart Failure After Myocardial Infarction: Altered Excitation-Contraction Coupling , 2001, Circulation.

[36]  A. Marks.  Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death. , 2001, Journal of molecular and cellular cardiology.

[37]  A. Trafford,et al.  No Role for the Ryanodine Receptor in Regulating Cardiac Contraction? , 2000, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[38]  S. Houser,et al.  Abnormalities of calcium cycling in the hypertrophied and failing heart. , 2000, Journal of molecular and cellular cardiology.

[39]  A. Marks,et al.  Cardiac intracellular calcium release channels: role in heart failure. , 2000, Circulation research.

[40]  D. Burkhoff,et al.  PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor) Defective Regulation in Failing Hearts , 2000, Cell.

[41]  S. Houser,et al.  Functional properties of failing human ventricular myocytes. , 2000, Trends in cardiovascular medicine.

[42]  D. Bers,et al.  Role of the sarcoplasmic reticulum in contraction and relaxation of immature rabbit ventricular myocytes. , 1997, Journal of molecular and cellular cardiology.

[43]  A. Marks.  Intracellular calcium-release channels: regulators of cell life and death. , 1997, The American journal of physiology.

[44]  G. Jennings,et al.  Adverse consequences of high sympathetic nervous activity in the failing human heart. , 1995, Journal of the American College of Cardiology.

[45]  J. Potter,et al.  Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation. , 1995, Circulation research.

[46]  J. Bridge,et al.  Relation between reverse sodium-calcium exchange and sarcoplasmic reticulum calcium release in guinea pig ventricular cells. , 1994, Circulation research.

[47]  W. Barry,et al.  Intracellular Calcium Homeostasis in Cardiac Myocytes , 1993, Circulation.

[48]  D. DeMets,et al.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.

[49]  R. Tsien,et al.  Mechanisms of calcium channel modulation by beta-adrenergic agents and dihydropyridine calcium agonists. , 1986, Journal of molecular and cellular cardiology.